Delivery Order SPE2DB20D3103-SPE2DB25FQ4J4
- Not listed
- AmerisourceBergen Drug Corp was awarded a $2,376.01 firm fixed-price delivery order by the Defense Logistics Agency on July 22, 2025, for the supply of Kerendia 20 mg tablets (30-count packages). This is a non-set-aside competitive award with a completion date of July 23, 2025. The contract is performed from the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Kerendia 10 mg tablets (30-count packaging) valued at $6,857.16. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at approximately $21,000 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (90-count units) on September 22, 2025, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania headquarters. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $4,080.81 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count package). This firm fixed price, non-set-aside delivery order was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Kerendia 10 mg tablets (30-count units) with a contract ceiling value of $59,930.82. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order valued at $2,737.75 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (90-count supply) on September 12, 2025, with completion scheduled for September 15, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,430.52 for Kerendia 10 mg tablets (90-count packaging) on July 15, 2025, with an ultimate completion date of July 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- This delivery order, awarded on September 22, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides $1,794.63 in funding for Kerendia 10 mg tablets (quantity 30) to support federal medical supply needs. The award represents a competitive, non-set-aside procurement with firm fixed pricing and a completion date of September 23, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,104.12 by the Defense Logistics Agency (DLA) on June 26, 2025, for the supply of Kerendia 20 mg tablets (30-count units). This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The contract is scheduled for ultimate completion on June 27, 2025, with performance taking place at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 30, 2025, for the supply of Kerendia 20 mg tablets (30-count packaging) with a ceiling value of $10,329.51. This firm fixed price delivery order, which represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical, is scheduled for completion by September 2, 2025. The award was competitively awarded with no set-aside designation and will be...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ4J4Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,550.08 on September 23, 2025, for the supply of Kerendia 10 mg tablets (30-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 24, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor supporting federal medical procurement needs across military and veteran healthcare systems. The company's portfolio encompasses a comprehensive range of pharmaceutical products and medical supplies delivered through the DLA supply chain, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The SPE2DX contract vehicle enables AmerisourceBergen to fulfill pharmaceutical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning the company as a critical vendor for federal medical logistics operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/23/25 |